Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Faster identification of new antibiotic candidates with the help of artificial intelligence: This is the goal of the research project ANTARES, funded by the German Federal Ministry for Research, Technology and Space (BMFTR). The consortium is collaborating to identify new, safe, and affordable treatment options for patients suffering from life-threatening and often drug-resistant infections.f

At Charité – Universitätsmedizin Berlin, six patients with particularly severe rheumatoid arthritis were treated with CD19 CAR-T cells. Disease activity decreased significantly in all participants. The researchers at Fraunhofer ITMP carried out the technological analysis of the study samples, particularly using the Olink platform. The results of this world's first clinical study have been published in the journal Nature Medicine.

The Fraunhofer ITMP today celebrated the topping-out ceremony for the new site of Immunology, Infection, and Pandemic Research (IIP) in Penzberg/Munich, after completion of the shell construction works. High-level representatives such as Dr. Markus Söder (Bavaria's Minister-President), Alexander Dobrindt (Federal Minister of the Interior), Hubert Aiwanger (Bavarian Minister of Economy, Regional Development and Energy), and Markus Blume (Minister of State for Science and Art) praised the construction progress and emphasized the great potential for biomedical innovations and international competitiveness.